Clinical Value of 131I in Diagnosis and Treatment of Recurrent Papillary Thyroid Carcinoma

Clinical Value of 131I in Diagnosis and Treatment of Recurrent Papillary Thyroid Carcinoma

The papillary thyroid cancer (PTC) patients have general good prognosis, but the relapse occurred in 20%-30% patients after initial treatment, which resulted in poor prognosis and treatment difficulty. 131I can act as a part of postoperative adjuvant therapy for the initial standard treatment of mid...

Full description

Bibliographic Details
Main Authors: JING Zhengjun, ZHANG Yaqi, BIE Shuang, FAN Qianyu, CHEN Jian
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2022-06-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
papillary thyroid cancer
relapse
131i
Online Access:http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.21.1214

Similar Items

Similar Items